查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968639

医用同位素生产市场分析及预测（至2035年）：类型、产品类型、服务、技术、应用、最终用户、製程、组件和模式

Medical Isotope Production Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Component, Mode
出版日期: | 出版商: Global Insight Services | 英文 325 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计医用同位素生产市场规模将从2024年的64亿美元成长到2034年的210亿美元，复合年增长率约为12.6%。医用同位素生产市场涵盖用于医学诊断和治疗的同位素的生产。这些同位素在核子医学程序中至关重要，包括诊断影像和癌症治疗。市场成长的驱动力来自医疗技术的进步、慢性病发病率的上升以及对精准诊断工具的需求。为了满足不断增长的需求并应对监管挑战，确保同位素的可靠供应和生产方法的创新至关重要。在基础设施和研发投资的推动下，该产业蓄势待发，即将迎来成长。

医疗用同位体生产市场は、诊断・治疗用途の需要増加を背景に坚调な成长を遂げております。诊断分野では、Technetium99mがその优れた特性から核子医学扫描术诊断で広く利用され、依然として主力同位体としての地位を维持しております。治疗分野では、ヨウ素131が甲状腺疾患や特定のがん治疗に広く用いられ、主要同位体としての地位を确立しております。続いて镏177が治疗分野、特に标靶放射性核治疗において注目を集めており、将来性が期待されています。生产方法においては、确立されたインフラと大规模生产能力を背景に、核子反应炉ベースの生产が主流を占めています。技术进歩と短寿命同位体への需要増加を背景に、サイクロトロンベースの生产が重要なサブセグメントとして台头しています。研究开発への投资は、同位体生产技术の革新と応用范囲の拡大において极めて重要です。医疗机関と生产施设间の戦略的连携は、世界の需要を満たし、サプライチェーンの回復力を确保する上で极めて重要です。

市场区隔
类型 放射性同位素，稳定同位素
产品 Technetium-99m、碘-131、氙-133、铊-201、镓-67、铱-192、锶-89、钇-90、碳-14
服务 同位素富集、客製化合成、放射性标记、物流配送、咨询服务、品质保证、法规遵循
科技 迴旋加速器、核子反应炉、线性加速器、中子活化分析、核分裂、核融合、放射性同位素产生器
目的 诊断、治疗、研究、工业、农业、环境研究、辐射安全
最终用户 医院、研究实验室、製药公司、学术机构、工业实验室、核子医学中心
过程 靶材照射、化学处理、纯化、品管、包装及配送
成分 靶材、辐照设备、加工设备、品管系统、包装解决方案
製造形式 本地生产、外包生产、契约製造

市场概况：

医用同位素生产市场参与企业众多，各自构成了一个充满活力的竞争格局。市场占有率主要受策略定价和创新同位素的推出影响。近期产品推出进一步加剧了竞争，各公司力求透过提高疗效和安全性来打造差异化产品。定价策略日趋复杂，反映了供应链物流和技术进步之间错综复杂的相互作用。北美仍然是主导的市场，而新兴市场在医疗投资增加和技术应用的推动下正经历强劲增长。医用同位素生产市场的竞争日益激烈，主要参与者透过策略联盟和收购争夺主导。法规结构，尤其是在北美和欧洲，对生产和分销设定了严格的标准，显着影响市场动态。这些法规在确保品质和安全的同时，也对新进入者构成了障碍。市场前景广阔，同位素应用技术和生产方法的创新将带来巨大的成长潜力。然而，监管合规和生产成本等挑战依然存在，需要策略远见和投资。

主要趋势和驱动因素：

受核医和放射性药物技术进步的推动，医用同位素生产市场正经历强劲成长。一个关键趋势是，由于慢性病发病率的上升，对诊断影像同位素（例如Technetium-99m）的需求不断增长。生产技术的创新也促进了这项需求的成长，并提高了同位素的可用性和安全性。此外，向核子反应炉生产方法（例如迴旋加速器技术）的转变，正在减少对核子反应炉的依赖，并最大限度地减少对环境的影响。监管支持和政府资助是该领域研发的关键驱动因素。新兴市场医疗基础设施的扩展也进一步推动了需求。此外，对个人化医疗和标靶治疗的日益重视，正在推动治疗性同位素（例如镏-177）的使用。投资于永续同位素生产和分销网络的公司将能够更好地掌握这些趋势。随着人们对核医益处的认识不断提高，该市场正处于持续成长和创新的黄金时期。

限制与挑战：

医用同位素生产市场面临许多重大限制与挑战。其中一个关键挑战是复杂且区域差异显着的监管环境，这导致核准延迟并增加合规成本。这种复杂性会抑制创新并减缓市场成长。供应链脆弱性也是一个重要的阻碍因素。对有限生产设施的依赖以及地缘政治紧张局势可能会扰乱同位素生产所需原材料的供应，导致短缺和成本上升。技术限制也构成挑战。医用同位素生产需要先进技术，这些技术成本高且难以维护，尤其对于新兴市场参与者而言。此外，该领域也面临熟练专业人员短缺的问题。同位素生产所需的专业知识并不普及，造成了人才瓶颈。最后，公众对核能技术的认知和安全担忧可能会阻碍市场扩张。对辐射的误解和恐惧可能会降低对医用同位素应用的需求和支持。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 放射性同位素
    • 稳定同位素
  • 市场规模及预测：依产品划分
    • Technetium-99m
    • 碘-131
    • 氙-133
    • 铊-201
    • 镓-67
    • 铱-192
    • 锶-89
    • 钇90
    • 碳-14
  • 市场规模及预测：依服务划分
    • 同位素富集
    • 客製合成
    • 放射性标记
    • 物流与配送
    • 咨询服务
    • 品质保证
    • 监理合规
  • 市场规模及预测：依技术划分
    • 迴旋加速器
    • 核子反应炉
    • 线性加速器
    • 中子活化分析
    • 核分裂
    • 核融合
    • 放射性同位素产生器
  • 市场规模及预测：依应用领域划分
    • 诊断
    • 治疗药物
    • 研究
    • 工业的
    • 农业
    • 环境研究
    • 辐射安全措施
  • 市场规模及预测：依最终用户划分
    • 医院
    • 研究所
    • 製药公司
    • 学术机构
    • 工业研究院
    • 核子医学中心
  • 市场规模及预测：依製程划分
    • 标靶照射
    • 化学处理
    • 纯化
    • 品管
    • 包装
    • 分配
  • 市场规模及预测：依组件划分
    • 目标物质
    • 照射装置
    • 加工设备
    • 品管系统
    • 包装解决方案
  • 市场规模及预测：依方法
    • 本地生产
    • 异地生产
    • 契约製造

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • SHINE Medical Technologies
  • NorthStar Medical Radioisotopes
  • Advanced Accelerator Applications
  • BWX Technologies
  • Eckert & Ziegler Strahlen-und Medizintechnik
  • ITM Isotopen Technologien Munchen
  • NTP Radioisotopes
  • Curium Pharma
  • Canadian Nuclear Laboratories
  • SCK CEN Belgian Nuclear Research Centre
  • Iotron Industries
  • ANSTO Health
  • Nordion
  • TerraPower
  • Cyclomedical Applications Group

第九章：关于我们

简介目录
Product Code: GIS34032

Medical Isotope Production Market is anticipated to expand from $6.4 billion in 2024 to $21 billion by 2034, growing at a CAGR of approximately 12.6%. The Medical Isotope Production Market encompasses the generation of isotopes for diagnostic and therapeutic applications in medicine. These isotopes are crucial for nuclear medicine procedures, including imaging and cancer treatment. The market is driven by advancements in healthcare technologies, increasing prevalence of chronic diseases, and the need for precise diagnostic tools. Efforts to secure reliable isotope supply and innovation in production methods are pivotal, as they address both rising demand and regulatory challenges. This sector is poised for growth, propelled by investments in infrastructure and research.

The Medical Isotope Production Market is experiencing robust growth, spurred by rising demand for diagnostic and therapeutic applications. In the diagnostic segment, Technetium-99m remains the top-performing isotope, widely utilized in nuclear medicine imaging due to its favorable properties. The therapeutic segment sees Iodine-131 as a leading isotope, extensively employed in the treatment of thyroid disorders and certain cancers. Following closely, Lutetium-177 is gaining traction in the therapeutic space, particularly for targeted radionuclide therapy, indicating a promising future. Among production methods, reactor-based production dominates due to its established infrastructure and capacity for large-scale output. Cyclotron-based production is emerging as a significant sub-segment, driven by advancements in technology and the growing need for short-lived isotopes. Investment in research and development is crucial, fostering innovation in isotope production technologies and expanding applications. Strategic collaborations between healthcare institutions and production facilities are pivotal in meeting global demand and ensuring supply chain resilience.

Market Segmentation
TypeRadioisotopes, Stable Isotopes
ProductTechnetium-99m, Iodine-131, Xenon-133, Thallium-201, Gallium-67, Iridium-192, Strontium-89, Yttrium-90, Carbon-14
ServicesIsotope Enrichment, Custom Synthesis, Radiolabeling, Logistics and Distribution, Consultation Services, Quality Assurance, Regulatory Compliance
TechnologyCyclotron, Nuclear Reactor, Linear Accelerator, Neutron Activation, Fission, Fusion, Radioisotope Generator
ApplicationDiagnostics, Therapeutics, Research, Industrial, Agricultural, Environmental Studies, Radiation Safety
End UserHospitals, Research Institutes, Pharmaceutical Companies, Academic Institutions, Industrial Laboratories, Nuclear Medicine Centers
ProcessTarget Irradiation, Chemical Processing, Purification, Quality Control, Packaging, Distribution
ComponentTarget Material, Irradiation Device, Processing Equipment, Quality Control Systems, Packaging Solutions
ModeOn-Site Production, Off-Site Production, Contract Manufacturing

Market Snapshot:

The Medical Isotope Production Market is characterized by a diverse array of market participants, each contributing to a dynamic competitive landscape. Market share is primarily influenced by strategic pricing and the introduction of innovative isotopes. Recent product launches have further intensified competition, as companies seek to differentiate their offerings by enhancing efficacy and safety. Pricing strategies are increasingly sophisticated, reflecting the complex interplay of supply chain logistics and technological advancements. North America remains a dominant force, yet emerging markets are witnessing robust growth, driven by increased healthcare investments and technological adoption. Competition within the Medical Isotope Production Market is intensifying, with key players vying for leadership through strategic alliances and acquisitions. Regulatory frameworks, particularly in North America and Europe, significantly impact market dynamics, setting stringent standards for production and distribution. These regulations ensure quality and safety but also pose barriers to entry for new players. The market's future is promising, with innovations in isotope applications and production methods offering significant growth potential. However, challenges such as regulatory compliance and production costs persist, necessitating strategic foresight and investment.

Geographical Overview:

The medical isotope production market is witnessing notable growth across various regions, each presenting unique opportunities. North America is at the forefront, driven by advanced healthcare infrastructure and increased demand for diagnostic imaging. The presence of leading pharmaceutical companies further propels the market. Europe follows, with significant investments in nuclear medicine and a strong emphasis on research and development. The region's commitment to healthcare innovation enhances its market potential. In Asia Pacific, rapid economic growth and expanding healthcare services are key drivers. Countries like China and India are emerging as pivotal players, investing heavily in medical isotope production capabilities. Latin America and the Middle East & Africa are nascent yet promising markets. In Latin America, growing healthcare awareness and infrastructure development fuel demand. Meanwhile, the Middle East & Africa are recognizing the importance of medical isotopes in advancing healthcare outcomes. These regions are poised for growth as they enhance their healthcare systems and invest in isotope production technologies.

Key Trends and Drivers:

The medical isotope production market is experiencing robust growth, driven by advancements in nuclear medicine and radiopharmaceuticals. A key trend is the increasing demand for diagnostic imaging isotopes, such as Technetium-99m, due to rising chronic disease prevalence. This surge is complemented by innovations in production technologies, enhancing isotope availability and safety. Moreover, the shift towards non-reactor-based production methods, like cyclotron technology, is gaining traction, reducing reliance on nuclear reactors and minimizing environmental impact. Regulatory support and government funding are pivotal drivers, as they facilitate research and development in this sector. The expansion of healthcare infrastructure in emerging markets further propels demand. Additionally, the growing emphasis on personalized medicine and targeted therapies is fostering the use of therapeutic isotopes, such as Lutetium-177. Companies investing in sustainable isotope production and distribution networks are well-positioned to capitalize on these trends. As awareness of nuclear medicine's benefits increases, the market is poised for sustained growth and innovation.

Restraints and Challenges:

The medical isotope production market encounters several significant restraints and challenges. A primary challenge is the regulatory landscape, which is complex and varies across regions, leading to delays in approvals and increased compliance costs. This complexity can hinder innovation and slow market growth. Supply chain vulnerabilities represent another critical restraint. The reliance on a limited number of production facilities and geopolitical tensions can disrupt the supply of raw materials necessary for isotope production, leading to shortages and increased costs. Technological limitations also pose a challenge. The production of medical isotopes requires sophisticated technology, which can be costly and difficult to maintain, especially for emerging market players. Additionally, there is a shortage of skilled professionals in the field. The specialized knowledge required for isotope production is not widely available, creating a bottleneck in workforce availability. Lastly, public perception and safety concerns about nuclear technology can impede market expansion. Misunderstandings and fears about radiation can reduce demand and support for medical isotope applications.

Key Players:

SHINE Medical Technologies, NorthStar Medical Radioisotopes, Advanced Accelerator Applications, BWX Technologies, Eckert & Ziegler Strahlen- und Medizintechnik, ITM Isotopen Technologien M\unchen, NTP Radioisotopes, Curium Pharma, Canadian Nuclear Laboratories, SCK CEN Belgian Nuclear Research Centre, Iotron Industries, ANSTO Health, Nordion, TerraPower, Cyclomedical Applications Group

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Component
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Radioisotopes
    • 4.1.2 Stable Isotopes
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Technetium-99m
    • 4.2.2 Iodine-131
    • 4.2.3 Xenon-133
    • 4.2.4 Thallium-201
    • 4.2.5 Gallium-67
    • 4.2.6 Iridium-192
    • 4.2.7 Strontium-89
    • 4.2.8 Yttrium-90
    • 4.2.9 Carbon-14
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Isotope Enrichment
    • 4.3.2 Custom Synthesis
    • 4.3.3 Radiolabeling
    • 4.3.4 Logistics and Distribution
    • 4.3.5 Consultation Services
    • 4.3.6 Quality Assurance
    • 4.3.7 Regulatory Compliance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cyclotron
    • 4.4.2 Nuclear Reactor
    • 4.4.3 Linear Accelerator
    • 4.4.4 Neutron Activation
    • 4.4.5 Fission
    • 4.4.6 Fusion
    • 4.4.7 Radioisotope Generator
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Diagnostics
    • 4.5.2 Therapeutics
    • 4.5.3 Research
    • 4.5.4 Industrial
    • 4.5.5 Agricultural
    • 4.5.6 Environmental Studies
    • 4.5.7 Radiation Safety
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Research Institutes
    • 4.6.3 Pharmaceutical Companies
    • 4.6.4 Academic Institutions
    • 4.6.5 Industrial Laboratories
    • 4.6.6 Nuclear Medicine Centers
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Target Irradiation
    • 4.7.2 Chemical Processing
    • 4.7.3 Purification
    • 4.7.4 Quality Control
    • 4.7.5 Packaging
    • 4.7.6 Distribution
  • 4.8 Market Size & Forecast by Component (2020-2035)
    • 4.8.1 Target Material
    • 4.8.2 Irradiation Device
    • 4.8.3 Processing Equipment
    • 4.8.4 Quality Control Systems
    • 4.8.5 Packaging Solutions
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 On-Site Production
    • 4.9.2 Off-Site Production
    • 4.9.3 Contract Manufacturing

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Component
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Component
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Component
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Component
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Component
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Component
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Component
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Component
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Component
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Component
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Component
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Component
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Component
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Component
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Component
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Component
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Component
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Component
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Component
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Component
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Component
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Component
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Component
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Component
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 SHINE Medical Technologies
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 NorthStar Medical Radioisotopes
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Advanced Accelerator Applications
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BWX Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Eckert & Ziegler Strahlen- und Medizintechnik
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 ITM Isotopen Technologien Munchen
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 NTP Radioisotopes
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Curium Pharma
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Canadian Nuclear Laboratories
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 SCK CEN Belgian Nuclear Research Centre
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Iotron Industries
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 ANSTO Health
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nordion
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 TerraPower
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Cyclomedical Applications Group
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us